Skip to main content
. Author manuscript; available in PMC: 2016 Jan 15.
Published in final edited form as: Clin Cancer Res. 2015 Jan 15;21(2):484–489. doi: 10.1158/1078-0432.CCR-14-1873

Table 2.

The demographic and clinical variables of an internal testing set of patients with either malignant or benign SPNs

67 Patients with malignant SPNs (stage I and II NSCLC)
69 Patients with benign SPNs
Age, Median (SD) 66.4 (7.9) 64.9 (SD 8.5)
Sex
 Female 24 (35.8%) 23 (33.3%)
 Male 43 (64.2%) 46 (66.7%)
Race
 African American 19 (28.4%) 20 (28.9%)
 White 48 (71.6%) 49 (70.1%)
Nodule size (cm)
 Median (SD) 2.5 (1.6) 1.8 (1.7)
 Range 0.5–4.5 0.1–3.9
Pack-years, Median (SD) 36.9 (SD 25.7) 34.6 (SD 32.5)
Stages
 stage I 45 (67.2%)
 stage II 22 (32.8%)
Histological types of NSCLC
 AC 30 (44.8%)
 SCC 31 (46.3%)
 Others 6 (8.9%)

Abbreviations: SPNs, solitary pulmonary nodules; SD, standard deviation; NSCLC, non-small-cell lung cancer; AC, adenocarcinoma; SCC, squamous cell carcinoma.